Back HCV Treatment Treatment Guidelines

HCV Treatment Guidelines

EASL Issues New Hepatitis C Treatment Recommendations For All Genotypes

The European Association for the Study of the Liver (EASL) released its latest recommendations on treatment of hepatitis C at a special meeting last week in Paris. The updated guidelines now include highly effective interferon-free options for all hepatitis C virus (HCV) genotypes and for the most challenging patients.

alt

Read more:

AASLD/IDSA Hepatitis C Guidelines Updated to Include New Therapies

The American Association for the Study of Liver Diseases, Infectious Diseases Society of America, and International Antiviral Society-USA this week updated their hepatitis C guidelines to add newly approved direct-acting antiviral (DAA) regimens, offering more options for people with HCV genotypes other than 1 or 4. The full guidance is available online at HCVguidelines.org.

alt

Read more:

Updated Hepatitis C Care and Treatment Guidelines Published in Hepatology

The latest updated U.S. recommendations for hepatitis C testing, management, and treatment, compiled by an expert panel of members of the American Association for the Study of Liver Diseases (AASLD) and partner organizations, have been published in the June 25 advance online edition of Hepatology, the AASLD's professional journal.

alt

Read more:

EASL 2016: WHO Issues New Hepatitis C Guidelines, EASL Guidelines Update Coming

In April, coinciding with the International Liver Congress in Barcelona, the World Health Organization (WHO) released an update to its Guidelines for the Screening, Care and Treatment of Patients with Chronic Hepatitis C Infection. The guidelines promote the transition to newer, more effective direct-acting antiviral (DAA) medications that have the potential to cure most people living with hepatitis C. Also during the meeting the European Association for the Study of the Liver (EASL) announced it would update its hepatitis C treatment guidelines at a special conference in September.

alt

Read more:

EASL 2015: New European Guidelines Prioritize Interferon-Free Hepatitis C Treatment

The European Association for the Study of the Liver (EASL) released its latest hepatitis C treatment guidelines at the 50th International Liver Congress taking place this week in Vienna. The guidelines recommend a variety of interferon-free direct-acting antiviral (DAA) regimens for people with hepatitis C virus genotypes 1-6. The panel offered recommendations for patient groups that remain difficult to treat, such as those with decompensated cirrhosis, but noted that more research is still needed in several areas. Also concurrent with the conference, EASL and the Latin American Association for the Study of the Liver released joint guidelines for non-invasive assessment of liver disease severity, noting that liver stiffness measurement is becoming the standard of care. 

alt

Read more: